Kimberly-Clark had its Relative Strength (RS) Rating upgraded from 80 to 85 Tuesday.
IBD's proprietary rating measures price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains often have an RS Rating of at least 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Kimberly-Clark broke out earlier, but has fallen back below the prior 149.31 entry from a consolidation. If a stock you're tracking climbs above a buy point then declines 7% or more below the original entry price, it's considered a failed base. It's best to wait for the stock to form a new pattern and breakout. Also keep in mind that the latest consolidation is a later-stage base, and such bases are more prone to failure.
Earnings growth declined in the company's latest report from 5% to -1%, but the top line rose from -4% to -1%.
The company holds the No. 9 rank among its peers in the Cosmetics/Personal Care industry group. ODDITY Tech, Prestige Consumer Hlthcr and Colgate-Palmolive are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
